Thomas Massie

Thomas Massie

Ask VT AI
View News Summary
  • Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
  • Devastating Russian missile and drone attack strikes Kyiv and other Ukrainian regions, killing at least 15 and injuring over 100, as Zelenskyy seeks international support at G7 summit.
  • US homebuilder sentiment plunges to a 2.5-year low as price cuts and sales incentives rise amid economic uncertainty.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
  • Devastating Russian missile and drone attack strikes Kyiv and other Ukrainian regions, killing at least 15 and injuring over 100, as Zelenskyy seeks international support at G7 summit.
  • US homebuilder sentiment plunges to a 2.5-year low as price cuts and sales incentives rise amid economic uncertainty.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Thomas Massie